Summary
This final report after the 6 months of allowing for final data analysis will show the value MRF provides for predicting the presenceabsence of lympnode involvement It will further demonstrate the value of IFP quantified via MRF for predicting response to therapy in this cohort of patients Correlation to results obtained via ScreenCell will provide further insight into the question whether CTC data help to increase the ability of MRF derived imaging biomarkers to predict metastatic potential
More information & hyperlinks
